Can’t find what you’re looking for? Just contact us and we’ll get back to you.
Empower your organization with a suite of forecasting tools designed to enhance decision-making and refine your commercial strategy.
Discover >
Streamline your business development and licensing strategies with actionable insights and informed decision making, supported by gold-standard data.
Enhance asset management with powerful tools that enable data-driven decisions and optimize your portfolio strategy for sustainable growth.
Stay ahead of the competition by leveraging competitive intelligence solutions to monitor market trends, anticipate competitor actions, and make strategic data-driven decisions.
Evaluate gives medical communications teams the market, pipeline and competitive intelligence they need to understand complex therapy areas, develop relevant communications strategies, and support clients with greater confidence.
Evaluate gives consulting teams the trusted market intelligence they need to answer difficult client questions, develop evidence-backed strategies, and deliver recommendations that stand up to scrutiny.
Build sharper valuation narratives for pharma and biotech M&A, IPOs and capital raising with trusted market data, forecasts, and evidence-backed insight.
Screen emerging pharma and biotech opportunities, assess asset potential, and track the market signals that could shape portfolio growth.
Assess pharma and biotech targets, pressure-test commercial assumptions, and support diligence with trusted market, product and competitor intelligence.
Track catalysts, forecast revisions, regulatory events, and competitive shifts that could affect pharma and biotech company valuations.
Press Release
To use this booking feature you need to accept all cookies. Please update your preferences to continue.
